Finance

Beta
Lists
IMRX:NASDAQ
Immuneering Corp
$5.05
+6.09%
(+0.29) 1D
$5.05
0.00% (0.00)
After hours
Closed: Jun 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMRX...
Open
$4.64
High
$5.14
Low
$4.64
Mkt. cap
326.72M
Avg. vol.
2.23M
Volume
1.94M
52-wk high
$10.08
52-wk low
$2.90
EPS
-$1.17
Beta
0.38
Shares outstanding
64.70M
No. of employees
55
Open
$4.64
High
$5.14
Low
$4.64
Mkt. cap
326.72M
Avg. vol.
2.23M
Volume
1.94M
52-wk high
$10.08
52-wk low
$2.90
EPS
-$1.17
Beta
0.38
Shares outstanding
64.70M
No. of employees
55
News stories
From sources across the web
About Immuneering Corp
CEO-
Employees55
Founded2008
Headquarters-
SectorBiotechnology
Websiteimmuneering.com
Analyst ratings
Based on 4 analysts giving stock ratings to IMRX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for IMRX in the last 3 months.
Highest
Current $5.05
$20.00 (+296.04%)
Average
$13.75 (+172.28%)
Lowest
$11.00 (+117.82%)
Analyst
Recommendation
Action
Price target
Projected
Date
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
$12.00
+137.6%
06/16/2026
Ami Fadia
Needham
Buy
Maintained
$11.00
+117.8%
06/02/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
$20.00
+296%
05/19/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
$12.00
+137.6%
04/21/2026
Jay Olson
Oppenheimer
Buy
Reiterated
$30.00
+494.1%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.45M
10.87M
9.25M
10.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.30M
4.51M
4.49M
4.68M
Operating expense
14.76M
15.38M
13.75M
15.34M
Total operating expenses
14.76M
15.38M
13.75M
15.34M
Operating income
-14.76M
-15.38M
-13.75M
-15.34M
Other non operating income
-
-
155.92K
109.01K
EBT including unusual items
-14.43M
-14.96M
-11.58M
-13.46M
EBT excluding unusual items
-14.43M
-14.96M
-11.74M
-13.87M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.43M
-14.96M
-11.58M
-13.46M
Net profit margin
-
-
-
-
Earnings per share
-0.40
-0.38
-0.18
-0.21
Interest and investment income
324.01K
415.83K
1.86M
1.36M
Interest expense
-
-
-
-
Net interest expenses
324.01K
415.83K
1.86M
1.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.67M
-15.29M
-13.67M
-15.25M
Gain or loss from assets sale
-
-
2.09K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer